Interested in
stocking our products?
Manoira works with retailers, veterinary clinics and specialist pet stores looking to offer their customers a patent-backed, pharmaceutical-grade cannabinoid range.
In partnership with
Sarborg
Manoira partners with Sarborg to leverage its Signature Intelligence and Quantum Computing capabilities across drug repurposing, novel combinations and molecular discovery.
Through this collaboration, Manoira gains access to a proprietary library of over 15,000 biological signatures. By mapping disease signatures against compound and combination signatures, Manoira can rapidly identify which indications its assets are most likely to succeed in, prioritising programmes with the strongest mechanistic fit before committing to costly preclinical and clinical work.
The same platform enables Manoira to design rational combination therapies. Quantum computing allows the partnership to evaluate vast numbers of molecule pairings and dosing strategies, surfacing synergistic combinations that complement existing standards of care and open new therapeutic windows across animal and human health.
The result is a sharper, evidence-led pipeline: faster indication selection, smarter combination design, and significantly improved R&D efficiency from candidate identification through to clinical translation.
To learn more about Sarborg's capabilities, please visit www.sarborg.com.